This series on Pharmacogenetic of Immunosuppresant Drugs is edited by Dr. Giovanni Pallio, from University of Messina, Messina, Italy.
Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
Dr. Giovanni Pallio works as a Research Fellow in the Clinical Pharmacology Unit of the Department of Clinical and Experimental Medicine in the University of Messina (Italy) and his research program is focused on the Pharmacogenetics of Immunosuppressant drugs and on the development of new therapeutic strategies for the treatment of IBDs. Dr. Pallio received his Pharm.D. degree in 2011 at the University of Messina and became Specialist in Clinical Pharmacology and Therapeutics with the grade of 70/70 and honor in 2017 at the University of Catania. Dr. Pallio obtained the PhD title in Biomedical, Clinical and Experimental Science with top marks and honor in 2020 at the University of Messina. In 2020 Dr. Pallio worked at the Wolfon Centre for Personalized Medicine in the Department of Pharmacology and Therapeutics at the University of Liverpool as Visiting Scientist on project about the evaluation of genetic polymorphisms and differences in Tacrolimus blood levels in transplant patients. Dr Pallio received the special award “SIF-Farmaindustria for Pharmacological Research” in 2020 for his researches in Clinical Pharmacology. Since 2013, he has published over 50 peer reviewed papers and his current H-index is 18.
The series “Pharmacogenetic of Immunosuppresant Drugs” was commissioned by the editorial office, Pharmacogenomics Research and Personalized Medicine without any sponsorship or funding. Giovanni Pallio is serving as the unpaid Guest Editor for the series.